Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Advertisement
Katy MarshallUpper Tract Urothelial Carcinoma | April 19, 2024
The only guideline-recommended endoluminal treatment option for patients with HG UTUC is bacillus Calmette-Guérin.
Read More
Zachary BessetteUpper Tract Urothelial Carcinoma | April 8, 2024
Patients who undergo RNU have comparative or better long-term outcomes than patients undergoing NSS for organ-localized UTUC.
Emily MenendezUpper Tract Urothelial Carcinoma | April 8, 2024
The nomogram is used preoperatively to determine the probability of nodal tropism.
Katy MarshallUpper Tract Urothelial Carcinoma | April 8, 2024
Previous trials have revealed that neoadjuvant chemotherapy is an effective treatment path for patients with high-grade UTUC.
James “Jed” Ferguson III, MD, PhDUpper Tract Urothelial Carcinoma | March 29, 2024
Dr. Ferguson sheds light on a national analysis evaluating the role of lymph node dissection in patients with high-risk UTUC.
Hooman Djaladat, MDUpper Tract Urothelial Carcinoma | March 28, 2024
Dr. Djaladat discusses how the presence of specific biomarkers, such as CK|V oncosomes and D|CK|V cells, correlate with RFS.
Alison Jane Birtle, MD, MBBS, MRCP, FRCRUpper Tract Urothelial Carcinoma | March 15, 2024
Dr. Birtle describes the utility of carboplatin versus cisplatin in this regimen and discusses metastasis-free survival.
Alison Jane Birtle, MD, MBBS, MRCP, FRCRUpper Tract Urothelial Carcinoma | March 21, 2024
Dr. Birtle highlights the trial's findings regarding the long-term overall survival benefit of adjuvant chemotherapy.
Alison Jane Birtle, MD, MBBS, MRCP, FRCRUpper Tract Urothelial Carcinoma | March 15, 2024
The POUT trial investigated adjuvant chemo for improving disease-specific survival in patients with UTUC.
Emily MenendezUpper Tract Urothelial Carcinoma | March 11, 2024
Liquid biopsy can benefit patients with UTUC by detecting rare events at higher incidences compared to tissue-based samples.
Katy MarshallUpper Tract Urothelial Carcinoma | March 1, 2024
Patients in the POUT trial were randomized to either a platinum-based adjuvant chemotherapy arm or a surveillance arm.
Katy MarshallUpper Tract Urothelial Carcinoma | March 11, 2024
Researchers investigated the ability of variant histology to predict oncological outcomes.
Emily MenendezUpper Tract Urothelial Carcinoma | December 20, 2023
The system provides a seal of the upper urinary tract to prevent urine leakage and can prevent the spread of tumor cells.
Emily MenendezUpper Tract Urothelial Carcinoma | December 12, 2023
Use of an sFI may increase accuracy in predicting complications and prognosis, as well as improve decision-making.
Christopher Wallis, MD, PhD, FRCSCUpper Tract Urothelial Carcinoma | March 11, 2024
Drs. Faltas and Wallis delve into the genomics of UTUC, including the evolution of disease and FGFR inhibition potential.
Christopher Wallis, MD, PhD, FRCSCUpper Tract Urothelial Carcinoma | December 18, 2023
Drs. Murray and Wallis discuss optimal patient selection, size criteria, and surgical ablation and chemoablation together.
Emily MenendezUpper Tract Urothelial Carcinoma | December 12, 2023
The nomogram outperformed 2 conventional models in predictive accuracy and showed higher benefit in decision curve analysis.
Roger Li, MDUpper Tract Urothelial Carcinoma | March 11, 2024
Dr. Li details what his study results suggested about ctDNA’s prognostic implications for survival in patients with UTUC.
Katy MarshallUpper Tract Urothelial Carcinoma | November 14, 2023
The study compared ureteroscopic surgery with radical nephroureterectomy.
Katy MarshallUpper Tract Urothelial Carcinoma | March 11, 2024
Researchers used whole-genome sequencing and a 152-gene panel to study the DNA of patients with high-risk UTUC.
Advertisement
Advertisement
Advertisement